Telo Genomics Corp. (TSXV:TELO)
0.0400
-0.0050 (-11.11%)
At close: Feb 9, 2026
-73.33% (1Y)
| Market Cap | 4.02M -60.1% |
| Revenue (ttm) | n/a |
| Net Income | -2.71M |
| EPS | -0.03 |
| Shares Out | 100.43M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 145,000 |
| Average Volume | 73,601 |
| Open | 0.0400 |
| Previous Close | 0.0450 |
| Day's Range | 0.0400 - 0.0400 |
| 52-Week Range | 0.0400 - 0.1500 |
| Beta | 0.04 |
| RSI | 41.36 |
| Earnings Date | Feb 25, 2026 |